Clinical Trial Update: MMF Monotherapy and Immune Regulation in Kidney Transplant Recipients: Part 1 Steroid Withdrawal [NA]

View source ↗

Summary

A completed clinical trial evaluating mycophenolate mofetil monotherapy with steroid withdrawal in kidney transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Renal Transplantation | NA | Status: COMPLETED